Skip to content
Clinical Trials – home
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Italy Largo Francesco Vito 1, 00168 Rome, Italy

About the sponsor

Clinical research in ovarian cancer, fallopian tube cancer, and primary peritoneal cancer includes advanced, recurrent, platinum-resistant, and HRD-guided treatment strategies, as well as studies in patients with disease involving the pelvis and peritoneum.

  • Advanced and recurrent ovarian malignancies
  • Platinum-resistant disease
  • Pelvic exenteration in gynecologic cancer
  • Pre-neoplastic vulvar and cervical lesions
  • Vulvar Paget's disease

Interest also extends to electrochemotherapy, pembrolizumab-based approaches, and biomarker-informed management of HPV-related and invasive gynecologic lesions.

About Specializations

Fondazione Policlinico Universitario Agostino Gemelli IRCCS runs clinical trials in conditions such as Ovarian cancer, Fallopian tube cancer, Malignant peritoneal neoplasm, Uveal melanoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

25 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Tebentafusp
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:[18F]Mc225
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Esomeprazole
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Tinzaparin Sodium
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Cervical dysplasia+1

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.